MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
Koninklijke Philips N.V. Cash and Cash Equivalents 2011-2026 | PHG
Annual Cash and Cash Equivalents Koninklijke Philips N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.79 B | 2.4 B | 1.87 B | 1.17 B | 2.3 B | 3.23 B | 1.42 B | 1.69 B | 1.94 B | 2.33 B | 1.77 B | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.23 B | 1.17 B | 2.08 B |
Quarterly Cash and Cash Equivalents Koninklijke Philips N.V.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 2.3 B | - | - | - | 3.23 B | - | - | - | 1.42 B | - | - | - | 1.69 B | - | - | - | 1.94 B | - | - | - | 2.33 B | - | - | - | 1.77 B | - | - | - | 1.87 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.23 B | 1.42 B | 2.07 B |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.48 B | $ 116.23 | 0.6 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 1.67 | - | $ 2.22 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 25.26 | 3.27 % | $ 702 M | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 21.52 | 1.37 % | $ 1.15 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Illumina
ILMN
|
1.13 B | $ 127.89 | 0.01 % | $ 20.3 B | USA |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 16.19 | -0.74 % | $ 490 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
214 M | $ 172.96 | 1.88 % | $ 8.57 B | USA |
 |
Guardant Health
GH
|
378 M | $ 90.69 | 2.0 % | $ 11.4 B | USA |
 |
Lantheus Holdings
LNTH
|
359 M | $ 84.36 | 0.04 % | $ 5.69 B | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 416.53 | 1.46 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 2.0 | 1.27 % | $ 8.85 M | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 7.07 | 0.21 % | $ 295 M | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
129 M | $ 9.6 | 0.58 % | $ 2.08 B | USA |
 |
Soleno Therapeutics
SLNO
|
70.1 M | $ 52.74 | 0.04 % | $ 2.68 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.17 | 1.4 % | $ 4.98 M | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 17.26 | 0.17 % | $ 386 M | USA |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 102.05 | -0.12 % | $ 8.42 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 265.38 | 0.62 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 470.88 | 0.28 % | $ 178 B | USA |
 |
Celcuity
CELC
|
166 M | $ 125.51 | 3.7 % | $ 5.87 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.65 | 0.03 % | $ 61.9 M | Irlanda |
 |
OpGen
OPGN
|
1.31 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 8.43 | 1.69 % | $ 1.08 B | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 60.75 | -0.31 % | $ 3.63 B | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.79 | 0.1 % | $ 444 M | USA |
 |
Natera
NTRA
|
466 M | $ 206.25 | 1.23 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 197.24 | 0.52 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
920 M | - | -0.91 % | $ 14.7 B | USA |